Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: Taiwan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20094
20132
20142
20151
20164
20172
20191
20201
20214
20221
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Unknown status4
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca2
Chugai Pharmaceutical2
Eli Lilly and Company2
GlaxoSmithKline2
Hoffmann-La Roche2
National Taiwan University Hospital2
Novartis Pharmaceuticals2
Biogen1
Blueprint Medicines Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular30
Liver Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Triple Negative Breast Neoplasms4
Neoplasm Metastasis3
Small Cell Lung Carcinoma3
Stomach Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Merkel Cell2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.